Cardiac Troponin, B-Type Natriuretic Peptide, D-dimer (3 in 1)
PDB ID: 1J1E, 1YK1, 2Q9I. Source: RCSB Protein Data Bank. For illustration purposes only.
VeriLumenTM cTnI+BNP+D-Dimer
The VeriLumenTM Cardiac Troponin I, B-Type Natriuretic Peptide & D-Dimer Rapid Test is a fluorescence immunochromatographic assay for the quantitative detection of cardiac troponin I (cTnI), B-type natriuretic peptide (BNP), and D-dimer in human whole blood or plasma samples. These biomarkers are associated with different cardiovascular and thrombotic conditions, allowing simultaneous assessment of myocardial injury, cardiac dysfunction, and coagulation activity. The assay provides rapid quantitative results to support timely clinical evaluation in laboratory and point-of-care settings.
cTnI is primarily used in the clinical assessment and auxiliary diagnosis of myocardial infarction, while BNP is commonly used in the evaluation of heart failure and cardiac stress. D-dimer is widely used in the assessment of coagulation and thrombotic disorders, including disseminated intravascular coagulation (DIC), thrombolytic therapy monitoring, and evaluation of suspected venous thromboembolic conditions. Combined quantitative measurement of these three biomarkers supports comprehensive cardiovascular assessment when interpreted together with clinical findings and other diagnostic information.
| Ref. Code | 808171 |
| Analyte | Cardiac Troponin I (cTnI), B-Type Natriuretic Peptide (BNP), D-dimer |
| Format | Fluorescence lateral flow immunoassay (cassette format) |
| Diagnostic Readout | Quantitative |
| Time to Result | 15 minutes |
| Measuring Range | cTnI: 0.05–30 ng/mLBNP: 5–5000 pg/mLD-Dimer: 0.05–10 mg/L |
| Reference Value | cTnI: < 0.3 ng/mLBNP: < 100 pg/mLD-Dimer: < 0.5 mg/L | R2 | ≥ 0.95 |
| Storage Conditions | 2–30°C |
| Shelf Life | 18 months |
| Certificate | CE, NMPA |
| Sample Types | Human whole blood, plasma or serum |
| Sample Volume | 100μL |
| Collection Method | Capillary (fingerstick) or venous blood |
| Sample Stability | Stable for testing within 1 hour at room temperature (as validated) |
| Acceptable Anticoagulants | EDTA / Heparin / Citrate (as applicable) |
| Notes on Handling | Specimens should be collected and handled using standard laboratory procedures. Use fresh samples when possible and avoid hemolyzed, lipemic, or contaminated specimens. |
| Detection Method | Quantitative fluorescence immunochromatography |
| Antibody Format | Multiplex / sandwich |
| Signal Generation | Fluorescence signal (fluorescent-labeled immunochromatography) |
| Reading Method | Instrument-based |
| Mechanism | The assay is based on a multiplex fluorescence immunochromatographic sandwich principle, in which cardiac troponin I (cTnI), B-type natriuretic peptide (BNP), and D-dimer present in the sample bind to their respective specific fluorescently labeled antibodies during capillary migration along the membrane. The resulting antigen–antibody complexes are captured at separate immobilized test regions, and the fluorescence signals are measured independently and correlated with the concentrations of cTnI, BNP, and D-dimer in the specimen. |
| Tests per Kit | 10/25/50 Tests |
| Dimension of Kit Box | 21 × 13.5 × 8 cm |
| Kits per Carton | 48 Kits |
| Tests per Carton (Bulk) | 1200 Tests |
| G.W. per Carton (Boxed) | 23.2 kg |
| G.W. per Carton (Bulk) | 26.2 kg |
| Carton Dimension | 67 × 57.5 × 39 cm |
| Carton Volume | 0.15 CBM |
| Packaging Format | Individual sealed test kits / bulk configuration (as applicable) | Items Included | - Test cassette - Desiccant- Sample diluent- ID chip- Instructions for Use |
| Storage & Shipping Conditions | Standard ambient transport; store according to product label requirements |
Let’s advance POCT diagnostics together
Shenzhen Kang Sheng Bao
Biotechnology Co., Ltd.
Second Floor, Block 3, Anda
Electronic Industrial Park,
Fuhai, Bao’an District,
518103 Shenzhen,
Guangdong Province, PRC
+86 0755 27417763
info@ksbbiotech.com